Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of an Extensively Hydrolyzed Formula in the Management of Cow's Milk Protein Allergy in Young Children: A Prospective, Single-Arm Interventional Study

NCT07855796 is registered in ClinicalTrials.gov with Shanghai Teyi Yinuo Health Technology Co., Ltd. as lead sponsor.

NCT NCT07855796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07855796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of an Extensively Hydrolyzed Formula in the Management of Cow's Milk Protein Allergy in Young Children: A Prospective, Single-Arm Interventional Study
Lead sponsor
Shanghai Teyi Yinuo Health Technology Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cow's milk protein allergy (cmpa)